{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:31:27Z","timestamp":1793025087404,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/WEA-011\/2013"],"award-info":[{"award-number":["SB\/WEA-011\/2013"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011753","name":"National Institute of Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR5474\/MED\/30\/824\/2012"],"award-info":[{"award-number":["BT\/PR5474\/MED\/30\/824\/2012"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nbd.2022.105876","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T12:27:23Z","timestamp":1663936043000},"page":"105876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP\/PS1 mice"],"prefix":"10.1016","volume":"174","author":[{"given":"Mayuri","family":"Khandelwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Manglani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105876_bb0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jcsm.12531","article-title":"AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy","volume":"11","author":"Abou-Samra","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.nbd.2022.105876_bb0010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","article-title":"Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study","volume":"75","author":"Ahtiluoto","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105876_bb0015","first-page":"625","article-title":"Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice","volume":"7","author":"Anderson","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.nbd.2022.105876_bb0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0028-1094063","article-title":"Glucose tolerance and plasma insulin of the rat in relation to the oestrous cycle and sex hormones","volume":"4","author":"Bailey","year":"1972","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.nbd.2022.105876_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.nbd.2022.105876_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature05354","article-title":"Resveratrol improves health and survival of mice on a high-calorie diet","volume":"444","author":"Baur","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2022.105876_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12264-013-1408-x","article-title":"Deregulation of brain insulin signaling in Alzheimer\u2019s disease","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.nbd.2022.105876_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beem.2013.06.006","article-title":"Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin","volume":"28","author":"Cheng","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2022.105876_bb0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","article-title":"Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy","volume":"85","author":"Choi","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.nbd.2022.105876_bb0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00125-011-2407-y","article-title":"Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle","volume":"55","author":"Chopra","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2022.105876_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.24.2.865-874.2004","article-title":"Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1","volume":"24","author":"Christensen","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2022.105876_bb0070","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1073\/pnas.1504890112","article-title":"Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP","volume":"112","author":"Corbett","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105876_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.trci.2017.05.002","article-title":"Alzheimer\u2019s disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.nbd.2022.105876_bb0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","article-title":"Insulin resistance and Alzheimer\u2019s disease","volume":"42","author":"de la Monte","year":"2009","journal-title":"BMB Rep."},{"key":"10.1016\/j.nbd.2022.105876_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0090","first-page":"NP544-51","article-title":"Relationship of PGC-1alpha gene polymorphism with insulin resistance syndrome in Korean children","volume":"27","author":"Ha","year":"2015","journal-title":"Asia Pac J Public Heal."},{"key":"10.1016\/j.nbd.2022.105876_bb0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0124","article-title":"Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer\u2019s disease","volume":"2","author":"Haan","year":"2006","journal-title":"Nat Clin Pr. Neurol"},{"key":"10.1016\/j.nbd.2022.105876_bb0100","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/BST0390891","article-title":"Diabetes as a risk factor for Alzheimer\u2019s disease: insulin signalling impairment in the brain as an alternative model of Alzheimer\u2019s disease","volume":"39","author":"Holscher","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2022.105876_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/abbs\/gmy152","article-title":"AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway","volume":"51","author":"Hu","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.nbd.2022.105876_bb0110","doi-asserted-by":"crossref","first-page":"17941","DOI":"10.1074\/jbc.M601372200","article-title":"Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105876_bb0115","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.nbd.2022.105876_bb0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fcvm.2019.00116","article-title":"Adiponectin\/AdipoR research and its implications for lifestyle-related diseases","volume":"6","author":"Iwabu","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nbd.2022.105876_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","article-title":"Co-expression of multiple transgenes in mouse CNS: a comparison of strategies","volume":"17","author":"Jankowsky","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.nbd.2022.105876_bb0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105876_bb0135","first-page":"10","article-title":"AdipoRon attenuates inflammation and impairment of cardiac function associated with cardiopulmonary bypass-induced systemic inflammatory response syndrome","author":"Jenke","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.nbd.2022.105876_bb0140","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2022.105876_bb0145","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1073\/pnas.1606171113","article-title":"PPARgamma-coactivator-1alpha gene transfer reduces neuronal loss and amyloid-beta generation by reducing beta-secretase in an Alzheimer\u2019s disease model","volume":"113","author":"Katsouri","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105876_bb0150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1681\/ASN.2017060627","article-title":"The adiponectin receptor agonist AdipoRon ameliorates diabetic nephropathy in a model of type 2 diabetes","volume":"29","author":"Kim","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.nbd.2022.105876_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2007.06.003","article-title":"Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake","volume":"6","author":"Kubota","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2022.105876_bb0160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.jnen.0000229236.98124.d8","article-title":"Formation of phospho-SAPK\/JNK granules in the hippocampus is an early event in Alzheimer disease","volume":"65","author":"Lagalwar","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0165","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","article-title":"BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions","volume":"25","author":"Laird","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105876_bb0170","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","article-title":"Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105876_bib396","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1038\/s41598-018-31318-4","article-title":"Specific alterations in astrocyte properties via the GluA2-GAPDH complex associated with multiple sclerosis","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.nbd.2022.105876_bb0175","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s00125-021-05473-9","article-title":"Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo","volume":"64","author":"Lindfors","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.nbd.2022.105876_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2022.105876_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","article-title":"Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer\u2019s disease","volume":"111","author":"Liu","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105876_bb0190","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2022.105876_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2022.105876_bb0200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exger.2016.12.019","article-title":"Glucose tolerance and insulin sensitivity are impaired in APP\/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline","volume":"88","author":"Macklin","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2022.105876_bb0205","first-page":"235","article-title":"Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer\u2019s disease","volume":"138","author":"Masliah","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2022.105876_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2022.105876_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030592","article-title":"Potential neuroprotective effects of adiponectin in Alzheimer\u2019s disease","volume":"18","author":"Ng","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2022.105876_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-016-0136-x","article-title":"Chronic adiponectin deficiency leads to Alzheimer\u2019s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice","volume":"11","author":"Ng","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2022.105876_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0210-y","article-title":"Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression","volume":"8","author":"Nicolas","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2022.105876_bb0230","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis","volume":"60","author":"O\u2019Connor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2022.105876_bb0235","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2022.105876_bb0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2022.105876_bb0245","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3233\/JAD-160572","article-title":"A\u03b2PP\/PS1 transgenic mice show sex differences in the cerebellum associated with aging","volume":"54","author":"Ordo\u00f1ez-Gutierrez","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2022.105876_bb0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer\u2019s disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2022.105876_bb0255","doi-asserted-by":"crossref","first-page":"11222","DOI":"10.1039\/C4CC03310H","article-title":"Benzothiazole derivatives augment glucose uptake in skeletal muscle cells and stimulate insulin secretion from pancreatic beta-cells via AMPK activation","volume":"50","author":"Pasternak","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.nbd.2022.105876_bb0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-110320","article-title":"JNK plays a key role in tau hyperphosphorylation in Alzheimer\u2019s disease models","volume":"26","author":"Ploia","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2022.105876_bb0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2022.105876_bb0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0275","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M116.738849","article-title":"Early growth response 1 (Egr-1) is a transcriptional activator of beta-secretase 1 (BACE-1) in the brain","volume":"291","author":"Qin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105876_bb0280","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.2147\/DDDT.S173970","article-title":"Mechanism involved in insulin resistance via accumulation of \u03b2-amyloid and neurofibrillary tangles: link between Type 2 diabetes and Alzheimer\u2019s disease","volume":"12","author":"Rad","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.nbd.2022.105876_bb0285","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1601-183X.2006.00221.x","article-title":"Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer\u2019s disease","volume":"6","author":"Reiserer","year":"2007","journal-title":"Genes. Brain. Behav."},{"key":"10.1016\/j.nbd.2022.105876_bb0290","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1172\/JCI67227","article-title":"AMPK, insulin resistance, and the metabolic syndrome","volume":"123","author":"Ruderman","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2022.105876_bb0295","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","article-title":"Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels","volume":"12","author":"Ruiz","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2022.105876_bb0300","first-page":"217","article-title":"Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach","author":"Salkovic-Petrisic","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2022.105876_bb0305","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2009.04.046","article-title":"Detection of behavioral alterations and learning deficits in mice lacking synaptophysin","volume":"162","author":"Schmitt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2022.105876_bb0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","article-title":"Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer\u2019s disease","volume":"122","author":"Shao","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2022.105876_bb0315","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease","volume":"35","author":"Simpson","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0320","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jne.12006","article-title":"Mineralocorticoid receptor activation induces insulin resistance through c-Jun N-terminal kinases in response to chronic corticosterone: cognitive implications","volume":"25","author":"Solas","year":"2013","journal-title":"J Neuroendocr."},{"key":"10.1016\/j.nbd.2022.105876_bb0325","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5115\/acb.2013.46.4.229","article-title":"Adiponectin as a new paradigm for approaching Alzheimer\u2019s disease","volume":"46","author":"Song","year":"2013","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.nbd.2022.105876_bb0330","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease - is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2022.105876_bb0335","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2022.105876_bb0340","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10571-020-01012-z","article-title":"Neuroprotective effect of 2-Aminoethoxydiphenyl borate (2-APB) in amyloid beta-induced memory dysfunction: a mechanistic study","volume":"42","author":"Thapak","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105876_bb0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"van der Heide","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105876_bb0350","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer\u2019s disease pathogenesis","volume":"25","author":"Velliquette","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105876_bb0355","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/acn3.436","article-title":"Importance of adiponectin activity in the pathogenesis of Alzheimer\u2019s disease","volume":"4","author":"Waragai","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nbd.2022.105876_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.687157","article-title":"Insulin resistance exacerbates Alzheimer disease via multiple mechanisms","volume":"15","author":"Wei","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2022.105876_bb0365","first-page":"1","article-title":"World Alzheimer report 2010: the global economic impact of dementia","author":"Wimo","year":"2010","journal-title":"London Alzheimer\u2019s Dis. Int."},{"key":"10.1016\/j.nbd.2022.105876_bb0370","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2022.105876_bb0375","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1074\/jbc.M602440200","article-title":"Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ","volume":"281","author":"Yan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105876_bb0380","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","article-title":"JNK3 perpetuates metabolic stress induced by Abeta peptides","volume":"75","author":"Yoon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2022.105876_bb0385","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s11064-019-02794-5","article-title":"AdipoRon protects against secondary brain injury after intracerebral hemorrhage via alleviating mitochondrial dysfunction: possible involvement of AdipoR1-AMPK-PGC1alpha pathway","volume":"44","author":"Yu","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2022.105876_bb0390","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1152\/ajpendo.00577.2014","article-title":"AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings","volume":"309","author":"Zhang","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2022.105876_bb0395","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122002686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122002686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:34:03Z","timestamp":1760852043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122002686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":80,"alternative-id":["S0969996122002686"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105876","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP\/PS1 mice","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105876"}}